SCHEMBL6596565

SCHEMBL6596565

COc1ccc(C(CCN2CCCN(c3nc4ccccc4n3CC(F)(F)F)CC2)CN(C)C(=O)c2cc(OC)c(OC)c(OC)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TACR2 P21452 6/20 0.40
TACR1 P25103 1/20 0.37
HRH1 P35367 2/20 0.37
KCNH2 Q12809 2/20 0.37
CYP2D6 P10635 1/20 0.37
MC4R P32245 1/20 0.36
MC5R P33032 1/20 0.36
MC3R P41968 1/20 0.36
MC1R Q01726 1/20 0.36
HTR1A P08908 1/20 0.36
CHRM1 P11229 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6596863 0.95 TACR2 (0.41) LMNAMAPTALDH1A1TSHRTDP1
SCHEMBL6593743 0.95 TACR2 (0.40) LMNAMAPTALDH1A1TACR2TACR1
SCHEMBL6595023 0.92 LMNA (0.41) LMNAMAPTALDH1A1TSHRTDP1
SCHEMBL6595439 0.92 TACR2 (0.52) TACR2TACR1
SCHEMBL6599589 0.92 LMNA (0.42) LMNAMAPTALDH1A1TSHRTDP1
SCHEMBL6595395 0.91 TACR2 (0.44) LMNAMAPTALDH1A1TSHRTDP1
SCHEMBL6597147 0.91 TACR2 (0.42) TACR2
SCHEMBL6597644 0.90 LMNA (0.45) LMNAMAPTALDH1A1TSHRTDP1
SCHEMBL6598857 0.90 ALDH1A1 (0.45) LMNAMAPTALDH1A1HRH1KCNH2
SCHEMBL6599264 0.89 HRH1 (0.45) LMNAMAPTALDH1A1TACR2TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888338-B1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES AVENTIS PHARMA INC (US) 2004-11-17 EP disclosed
EP-0888338-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1999-01-07 EP disclosed
WO-1997030991-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1997-08-28 WO disclosed